根据最新的财务报表(Form-10K),Infrax Systems Inc 的总资产为 $0,净损失为 $0
CSTF 的关键财务比率是什么?
Infrax Systems Inc 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Curascientific Corp 的收入按细分市场或地理位置如何划分?
Infrax Systems Inc 最大收入来源是 Fiber Optic Management Software System,在最近的收益报告中收入为 170。就地区而言, United States 是 Infrax Systems Inc 的主要市场,收入为 170。
Curascientific Corp 是否盈利?
不,根据最新的财务报表,Infrax Systems Inc 的净损失为 $0
Curascientific Corp 有负债吗?
不,Infrax Systems Inc 的负债为 0
Curascientific Corp 的流通股有多少?
Infrax Systems Inc 的总流通股为 1,411.91
关键数据
前收盘价
$0.0001
开盘价
$0
当日区间
$0 - $0.0001
52周范围
$0 - $0.0001
交易量
200.0K
平均成交量
16.5K
股息收益率
--
每股收益(TTM)
0.04
市值
$430.0K
什么是 CSTF?
CuraScientific Corp. is a bioscience company, which engages in the manufacture of commercial chemical products with applications in commercial sterilization for agriculture, warehousing, hospitality, and medical facilities. The company is headquartered in Nevada City, California. The company went IPO on 2001-10-16. The company has developed an effective germ fighter, DiOx+, a disinfectant sterilizer that kills 99.99% of harmful pathogens without dangerous toxic exposure to the user or the environment. Its DiOx+ is an activated chlorine dioxide (Cl02) broad spectrum disinfectant that kills dangerous pathogens with no residual toxicity. The company protects the environment and human health from viruses, bacteria and harmful by-products left by other cleaning sanitizers, without a harsh smell or skin irritation. DiOx+ helps protect agricultural crops from disease and other pathogens like mold and fungus. The company is used in water treatment plants, and helps reduce operational costs in warehousing, distribution centers, and ecommerce support facilities.